Update shared on 15 Nov 2025
Analysts have reaffirmed Innospec’s fair value estimate at $107.50 per share. They cite stable market conditions and modest improvements in profitability as factors supporting their unchanged outlook.
What's in the News
- The company has completed the repurchase of 246,528 shares, representing 0.99% of company shares, for $22.2 million as part of the buyback announced in March 2025 (Key Developments).
- The company declared a semi-annual dividend of 87 cents per common share for the second half of 2025, payable on November 26, 2025 to shareholders of record as of November 18, 2025 (Key Developments).
- The Performance Chemicals business is entering its second year partnering with International Justice Mission to protect palm oil workers in Indonesia, expanding training, support, and advocacy initiatives to new provinces in 2025 (Key Developments).
Valuation Changes
- Fair Value: The fair value estimate remains unchanged at $107.50 per share.
- Discount Rate: The discount rate has risen slightly from 7.32% to 7.37%.
- Revenue Growth: Projected revenue growth increased marginally from 4.23% to 4.24%.
- Net Profit Margin: Net profit margin improved significantly, rising from 19.97% to 27.37%.
- Future P/E: The future price-to-earnings ratio has decreased notably from 7.88x to 5.76x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.